Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
AAHRPP Accredits Three More Research Organizations 2019-03-22 23:06
WuXi AppTec Reports Strong 2018 Annual Results 2019-03-22 20:47
Exyte demonstrates high-potential digital Smart Fab Solution at SEMICON China 2019 2019-03-22 09:00
Equipping "Good Village Doctors" with AI technology 2019-03-21 21:46
CStone receives approval in China to initiate Phase 1 clinical trial for RET inhibitor BLU-667 (CS3009) 2019-03-21 21:32
eCommerce Channels Find High Penetration for Drug and Medical Device Sales 2019-03-21 21:11
Inovio's Ebola Vaccine Delivered Intradermally Demonstrates 100% Immunogenicity in a Clinical Study Published in The Journal of Infectious Diseases 2019-03-21 21:11
Sasol Offers Support to Cyclone Idai Victims 2019-03-21 20:06
Visiopharm Earns Acclaim from Frost & Sullivan for Transforming Anatomic Pathology with its Cross-platform Software Solutions 2019-03-21 20:00
VisualDx's Web-based Clinical Decision Support System Acknowledged by Frost & Sullivan as Best in Class 2019-03-21 20:00
Adlai Nortye Receives NMPA Approval for Pelareorep (AN1004) in China to Initiate Phase III Clinical Trials 2019-03-21 18:21
Research from XJTLU advances RNA modification mapping 2019-03-21 16:42
Fueling the Pharmaceutical Industry by Cutting-edge Design, InnoPack China to be Grandly Held in June 2019-03-21 15:00
Samsung BioLogics Wins 2019 CMO Leadership Awards in All Six Core Categories Three Years in a Row 2019-03-21 13:42
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody 2019-03-21 07:21
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody 2019-03-21 07:20
Beckman Coulter's New Procalcitonin Assay Helps Physicians Accurately Identify Patients at Risk for Progression to Septic Shock 2019-03-21 07:00
3SBio Unveils 2018 Annual Results: Revenue Soars by 22.7%, Normalized Net Profit Soars by 29.0%, R&D Expenses Jumps Over 40% 2019-03-21 00:14
Merck and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer 2019-03-20 18:27
Merck Opens First M Lab™ Collaboration Center in Europe 2019-03-20 17:30
1 929 930 931 932 933 1627